Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
SomnoMed Limited (SOM.AX)
AUD0.46
+0.00 (+0.00%)
AU ASX Healthcare Medical - Devices
Address
20 Clarke Street 2065
Crows Nest, NSW, AU
Crows Nest, NSW, AU
CEO
Amrita Howell
Website
somnomed.com
IPO
2004-08-27
ISIN AU000000SOM1
Also trades on
Australian Securities Exchange · SOM.AX (AUD)
Other OTC · SOMNF (USD)
Description
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
AUD0.46
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
81.7K
Beta
0.81
Float Shares
168.88M
Free Float %
77.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.88% | +4.55% | +2.68% | -21.23% | -27.67% | -25.57% | -4.17% | -8.59% | -66.37% | -37.84% | -37.84% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.46
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
4.12
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+21.7% ★ Q4'25: +34.6% (vs Q4'23)
-
EPS growth Medical - Devices: +28.5%+83.7% ★ Q4'25: +106.9% (vs Q4'23)
-
FCF margin FCF growth · Medical - Devices: +30.9%-6.9% Q4'25: +2.9% (vs Q4'23)
-
EBIT margin Medical - Devices: +6.2%-0.3% Q4'25: +4.6% (vs Q4'23)
-
ROIC Medical - Devices: +3.3%-0.8% Q4'25: +14.6% (vs Q4'23)
-
Share dilution Medical - Devices: 0.0%+75.5% Q4'25: +79.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×5.07× ★ Q4'25: 0.62× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2011 actual |
Jun 2012 actual |
Jun 2013 actual |
Jun 2014 actual |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 3 Rev. Ana. 2 EPS Ana. |
Jun 2027 3 Rev. Ana. 2 EPS Ana. |
Jun 2028 3 Rev. Ana. 2 EPS Ana. |
Jun 2029 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
12.51M
est: 13.14M (-4.8%)
|
15.33M
est: 14.82M (+3.4%)
|
18.49M
est: 19.03M (-2.8%)
|
30.27M
est: 26.17M (+15.7%)
|
34.44M
est: 31.65M (+8.8%)
|
44.08M
est: 44.50M (-0.9%)
|
49.33M
est: 50.39M (-2.1%)
|
52.39M
est: 64.20M (-18.4%)
|
58.89M
est: 63.75M (-7.6%)
|
57.30M
est: 57.00M (+0.5%)
|
62.71M
est: 65.25M (-3.9%)
|
72.58M
est: 72.58M (+0.0%)
|
83.62M
est: 83.62M (+0.0%)
|
91.65M
est: 91.65M (0.0%)
|
111.49M
est: 111.50M (0.0%)
|
122.65M
121.32M – 124.62M
+10.0% YoY
|
133.71M
130.23M – 137.73M
+9.0% YoY
|
146.34M
146.34M – 146.34M
+9.4% YoY
|
142.40M
139.72M – 145.72M
-2.7% YoY
|
| EBITDA |
742.3K
est: 161.3K (+360.3%)
|
900.3K
est: 755.8K (+19.1%)
|
707.8K
est: 526.4K (+34.4%)
|
849.4K
est: 275.0K (+208.8%)
|
573.3K
est: 533.0K (+7.6%)
|
1.51M
est: 1.06M (+42.4%)
|
-2.51M
est: 667.7K (-476.1%)
|
3.67M
est: -3.85M (+195.3%)
|
3.12M
est: 782.6K (+298.3%)
|
4.31M
est: -3.02M (+242.6%)
|
3.57M
est: 82.8K (+4,216.4%)
|
524.5K
est: 94.9K (+452.6%)
|
698.4K
est: 107.4K (+550.5%)
|
-2.33M
est: 120.2K (-2,037.7%)
|
1.58M
est: 1.37M (+15.7%)
|
1.51M
1.49M – 1.53M
+10.0% YoY
|
1.64M
1.60M – 1.69M
+9.0% YoY
|
1.80M
1.80M – 1.80M
+9.4% YoY
|
1.75M
1.72M – 1.79M
-2.7% YoY
|
| EBIT |
521.5K
est: -513.1K (+201.6%)
|
458.7K
est: 755.8K (-39.3%)
|
251.4K
est: 757.6K (-66.8%)
|
314.7K
est: 426.3K (-26.2%)
|
40.7K
est: 285.1K (-85.7%)
|
501.5K
est: 972.4K (-48.4%)
|
-3.74M
est: 556.7K (-772.4%)
|
1.98M
est: -4.92M (+140.2%)
|
918.5K
est: -2.49M (+136.9%)
|
1.22M
est: -3.86M (+131.6%)
|
-264.7K
est: 926.7K (-128.6%)
|
-3.41M
est: 1.06M (-421.2%)
|
-4.42M
est: 1.20M (-467.8%)
|
-8.10M
est: 1.34M (-702.7%)
|
-311.0K
est: -4.35M (+92.9%)
|
-4.79M
-4.87M – -4.74M
-10.0% YoY
|
-5.22M
-5.38M – -5.09M
-9.0% YoY
|
-5.72M
-5.72M – -5.72M
-9.4% YoY
|
-5.56M
-5.69M – -5.46M
+2.7% YoY
|
| Net Income |
739.5K
est: 2.46M (-69.9%)
|
524.7K
est: 834.8K (-37.1%)
|
588.8K
est: 667.7K (-11.8%)
|
405.9K
est: 811.3K (-50.0%)
|
597.2K
est: 508.2K (+17.5%)
|
165.0K
est: 832.0K (-80.2%)
|
-3.34M
est: 187.2K (-1,886.4%)
|
2.32M
est: -4.37M (+153.0%)
|
-39.4K
est: -7.34M (+99.5%)
|
-1.12M
est: -3.43M (+67.4%)
|
-1.19M
est: -1.39M (+14.0%)
|
-4.44M
est: -1.59M (-179.0%)
|
-8.00M
est: -7.87M (-1.7%)
|
-12.24M
est: -2.70M (-353.4%)
|
-3.46M
est: 2.00M (-272.5%)
|
2.70M
2.56M – 3.63M
+34.8% YoY
|
6.25M
3.59M – 8.65M
+131.5% YoY
|
8.10M
4.93M – 11.88M
+29.6% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
5.31M
est: 7.55M (-29.7%)
|
7.18M
est: 5.99M (+19.9%)
|
9.10M
est: 9.22M (-1.3%)
|
13.24M
est: 12.51M (+5.8%)
|
16.11M
est: 16.41M (-1.8%)
|
20.69M
est: 22.44M (-7.8%)
|
27.18M
est: 23.47M (+15.8%)
|
23.17M
est: 35.50M (-34.7%)
|
27.19M
est: 36.63M (-25.8%)
|
25.90M
est: 27.86M (-7.0%)
|
33.60M
est: 32.13M (+4.6%)
|
42.31M
est: 36.82M (+14.9%)
|
49.14M
est: 41.66M (+18.0%)
|
56.55M
est: 46.62M (+21.3%)
|
61.29M
est: 64.07M (-4.3%)
|
70.48M
69.71M – 71.61M
+10.0% YoY
|
76.84M
74.83M – 79.14M
+9.0% YoY
|
84.09M
84.09M – 84.09M
+9.4% YoY
|
81.83M
80.29M – 83.74M
-2.7% YoY
|
| EPS |
0.02
est: 0.01 (+31.8%)
|
0.01
est: 0.01 (+4.7%)
|
0.01
est: 0.01 (+70.3%)
|
0.01
|
0.01
est: 0.00 (+4,100.0%)
|
0.00
est: 0.02 (-78.6%)
|
-0.06
est: -0.03 (-103.2%)
|
0.04
est: -0.02 (+287.5%)
|
-0.23
est: -0.03 (-564.2%)
|
-0.02
est: 0.01 (-385.5%)
|
-0.01
est: 0.02 (-181.6%)
|
-0.05
est: -0.03 (-87.1%)
|
-0.10
est: -0.02 (-298.8%)
|
-0.10
est: -0.02 (-400.0%)
|
-0.02
est: 0.01 (-303.8%)
|
0.02
0.01 – 0.02
+88.3% YoY
|
0.03
0.02 – 0.04
+92.7% YoY
|
0.04
0.02 – 0.06
+36.6% YoY
|
—
— – —
-100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
11.26M
OE per share TTM
0.07
Owner's Yield
9.03%
Maintenance CapEx ratio
40.87%
Maint CapEx / Avg PPE
13.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-1.0K
Shares Outstanding
219.08M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Amrita Blickstead | Co-CEO & Executive Director | 894.0K | female |
| Karen Borg | Co-CEO & Executive Director | 894.0K | female |
| Marco Van Kleef | President of Europe | 557.5K | male |
| Ye-Fei Guo | Chief Financial Officer | 341.7K | female |
| Jonathan Vowels | Vice President of Manufacturing & Operations | — | male |
| Keshan Gunasinghe | Chief Product Officer | — | male |
| Nathan Minnich | Chief Marketing Officer | — | male |
| Greg Knight | Chief Transformation Officer | — | male |
| David Lewis | Chief Information Officer | — | male |
| Janice Hiskett-Jones | Chief People Officer | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SOM.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
